Disclosure Logs
| ATI 222 | Request withdrawn |
| ATI 221 | Request for information relating to R&D Competition 2012/2013 |
| ATI 220 | Request for list of drugs reported under Suspected Adverse Reaction |
| ATI 219 | Request for information relating to the Veterinary Medicines Directorate’s bonus payments |
| ATI 218 | Request for information about the VMD's use of the Regulation of Investigatory Powers Act 2000 (RIPA) and the Regulation of Investigatory Powers Act 2000 Scotland (RIPSA) |
| ATI 217 | Follow-up request to ATI 210 below |
| ATI 216 | Request for information relating to feline veterinary medicines by injection |
| ATI 215 | Request seeking ICT Contracts Update |
| ATI 214 | Request for information relating to Calmex |
| ATI 213 | Follow up to ATI 206 request for information relating to Metacam |
| ATI 212 | Request for information relating to reported failures of parvovirus vaccine |
| ATI 211 | Request for details of any currently valid market authorisations for Hydrogen Peroxide based products for use in treating salmon for sea lice infestations |
| ATI 210 | Request for information relating to recruitment contracts |
| ATI 209 | Request for certain information relating to an inspection report |
| ATI 208 | Request for details of the use of powers of entry by the Veterinary Medicines Directorate (VMD) under any of the relevant Acts or items of secondary legislation during the period 2008 - 2011, excluding Trading Standards investigations. |
| ATI 207 | Environmental Information Regulations request for environmental information on Nitroxynil |
| ATI 206 | Request for information relating to Metacam |
| ATI 205 | Request for information contained in or relating to the EPAR for Cardisure |
| ATI 204 | Request for end-point data are held by VMD on toxicity of florfenicol on terrestrial organisms |
| ATI 203 | Wide ranging request relating to egg testing under the VMD's statutory residues surveillance scheme |
| ATI 202 | Wide ranging request relating to ICT |
| ATI 201 | Request for the total electrical load of IT equipment used to process the VMD's data |
| ATI 200 | Request relating to Trade Union funding and staff time - Defra replied covering the core Department and its Agencies |
| ATI 199 | Request for information about a Novartis product: Vetrazin. |
| ATI 198 | Request for all ICT Contracts and other specified information relating to mobiles phones and PBX Maintenance. |
| ATI 197 | Request for information about the full monetary value of the Analytical Testing contract for the 2011 & 2012 GB National Residues Control Plan (excluding honey and Northern Ireland samples). |
| ATI 196 | Request for information about flukicide triclabendazole - in particular whether it is excreted in faeces and whether it has any insecticidal effects. |
| ATI 195 | Request for information about the use of Government Procurement Cards. |
| ATI 194 | Request for information relating to ICT. |
| ATI 193 | Request for information on excipients used in injectable formulations, particularly Ivomec Classic Injection for Cattle and Sheep (Ivermectin) |
| ATI 192 | Request for information about the UK Government's online services. |
| ATI 191 | Request withdrawn by applicant. |
| ATI 190 | Request for information about ecotoxic effects of veterinary medicines given to cows - ecotoxicity data about closantel. |
| ATI 189 | Request for reports/assessments/analyses and communications relating to use of antibiotics in agriculture and implications for human health. |
| ATI 188 | Request for 5 unpublished genotoxicity study reports and 1 unpublished review of genotoxicity commissioned by CEVA reports relating to fumagillin dicyclohexylamine. |
| ATI 187 | Request for information relating to the nature and cost of the payments processing that the VMD undertake. |
| ATI 186 | Request for information relating to how many veterinary pharmaceutical companies are licensed under the VMD & how much aggregate revenue did they accrue in a recent year? (2009? 2008?). |
| ATI 185 | Request for information for each of the SPECIAL IMPORT CERTIFICATES (SIC) issued in the 2010 calendar year: a) Name of product, b) product authorisation number and country of origin, and c) number of animals treated. |
| ATI 184 | Request for information about a number of Defra pilot studies. |
| ATI 183 | Request for information relating to ICT. |
| ATI 182 | Request for information relating to suspected adverse reaction reports involving feline vaccines. |
| ATI 181 | Request for information relating to the average monthly number of prescriptions items prescribed by Veterinary practice in England for 2010, with the practice name and county. |
| ATI 180 | Request for information relating to Copinox Ewe/Calf 4g Capsule. |
| ATI No. | Subject |
|---|---|
| ATI 179 | Request for information on the total number of the Veterinary Medicines Directorate employees at the end of financial year 2009-10 and the total spent on Veterinary Medicines Directorate employees during financial year 2009-10. |
| ATI 178 | Request for information since 12th May 2010 relating to the Coalition Government's Comprehensive Spending Review and the Coalition Government's Public Bodies Review. |
| ATI 177 | Request for information about voluntary redundancies. |
| ATI 176 | Request for information about additional statistics on veterinary antimicrobial use: veterinary usage in kgs of third and fourth generation cephalosporins in 2009; and veterinary usage in kgs of lincomycin in 2009. |
| ATI 175 | Request if an Animal Testing Certificate (ATC) was applied for and granted for an attached study relating to the product: Zactran (Gamithromycin).
Information requested related to:
|
| ATI 174 | Request for wide range of corporate information including copy of VMD briefing to new Minister. |
| ATI 173 | Request for correspondence relating to the handling of earlier request (ATI 159). Most information provided. VMD provided ICO with documents on case in late December. VMD awaiting results of ICO review. |
| ATI 172 | Request for information about the total amount of money spent by the VMD supporting environmentalist groups in 2009/10. |
| ATI 171 |
Request whether VMD hold market authorisations for the following veterinary medicinal products:
|
| ATI 170 | Request for information relating to staff numbers and HR/payroll services. |
| ATI 169 | Request for information relating to staff in Communications and Procurement. |
| ATI 168 | Request for information relating to staff in Finance, Procurement and ICT. |
| ATI 167 | Request for details of Marketing Authorisation for three products for treating salmon with sea lice using hydrogen peroxide. The products are Salartect registered by Brenntag, and Paramove and Samaki SLT registered by Interox Solvay. Copies of approvals, MSDS sheets, label instructions and details on methods of application. |
| ATI 166 | Subject access request under DPA. |
| ATI 165 | Request for further information on Epiphen. |
| ATI 164 | Request for information about the total amount of money paid to trade unions by Veterinary Medicines Directorate and the amount of staff time spent on union activities by Veterinary Medicines Directorate employees. |
| ATI 163 | Request to disclose the inspection report on the Bush House Veterinary Group. Request refused: Upheld on Internal Review. Requestor appealed to ICO. Requestor withdrew complaint following provisional view from ICO. |
| ATI 162 | Request for documentation on the Gateway 5 review of the 2005 VMD contract with the LGC for analytical services (RMP2260). |
| ATI 161 | Request for copies of the bioequivalence test data/reporting associated with/undertaken for Epiphen. |
| ATI 160 | Request withdrawn by applicant. |
| ATI 159 | Request for information concerning sea lice treatments used in salmon farms in Scotland. Most information provided after internal review. Requestor appealed to ICO. VMD provided ICO with documents on case in late December. VMD awaiting results of ICO review. |
| ATI 158 | Request for a copy of the hospitality and gift register for each of the years 2007, 2008 and 2009 inclusive. |
| ATI 157 | Request for information relating to how many cats need veterinary treatment after accidentally being treated by dog flea drops by their owners. |
| ATI 156 | Request for information relating to any person employed by VMD (either as a staff member, a freelancer, a contractor), who was paid over £100,000. |
| ATI 155 | Request for information relating to ICT. |
| ATI 154 | Request for information relating to Flood planning. |
| ATI 153 | Since 1 April 2008, how much the organisation paid to suppliers in interest for late payment pursuant to the Late Payment of Commercial Debts (Interest) Act 1998 and b) the total value of the suppliers' invoices concerned. |
| ATI 152 | Since 8 October 2008 to date, a) how much the organisation paid to suppliers in interest for late payment pursuant to the Late Payment of Commercial Debts (Interest) Act 1998 and b) the total value of the suppliers' invoices concerned. |
| ATI 151 | Since 8 October 2008 to date, a) the number of suppliers who have not been paid within 10 days and b) the total value of the suppliers' invoices concerned. |
| ATI 150 | Since 8 October 2008 to date, the percentage of suppliers' invoices that a) have and b) have not been paid within 10 days. |
| ATI 149 | Request for agency corporate publications |
| ATI 148 | Request for information relating to veterinary lincomycin usage statistics for 2008 |
| ATI 147 | Request for all information that VMD hold that is directly or indirectly related to the Norbrook teat seal, created/received on and between the 1 August 2009 and the 21 December 2009. |
| ATI No. | Subject |
|---|---|
| ATI 146 | Request for information relating to staff numbers. |
| ATI 145 | Request for information relating a formulation and its equivalence to that employed for the Virbac Effipro spot-ons. |
| ATI 144 | Request for information relating food procured and Christmas parties hosted by VMD. |
| ATI 143 | Request for information relating to the the VMD's staff contacts. |
| ATI 142 | Request withdrawn by applicant. |
| ATI 141 | Request for information relating product characterization for immunological preparations as well as labeling, field trials and scientific studies - coccidiosis vaccine. |
| ATI 140 | Request for information relating to the VMD's key contacts. |
| ATI 139 | Request withdrawn. |
| ATI 138 | Request for information relating to the VMD's income and staffing. |
| ATI 137 | Request for information relating to the cost of developing, running and managing the VMD website and job descriptions. |
| ATI 136 | Request for information relating total number of STCs/SICs approved in the last 18 months |
| ATI 135 | Request for information relating to research requirements. |
| ATI 134 | Request for information relating to the related to the Norbrook teat seal. |
| ATI 133 | Request for information relating to the Long March product |
| ATI 132 | Request for information relating Information Communication Technology strategy and costs. |
| ATI 131 | Request for information relating to committee structures. |
| ATI 130 | Request for information relating to corporate structure within the VMD and ICT strategy. |
| ATI 129 | Request for all expenses claimed by the chairman and chief executive of your organisation during the financial year 2008-2009; and a list of the travel expenses claimed by the chairman and chief executive, broken down into the following categories: car mileage, taxi/private hire car, rail and air. |
| ATI 128 | Request for information relating to public funding of the VMD, to people seconded to the VMD and jobs advertised. |
| ATI 127 | Request for a list of all events hosted by your organisation, at a cost of £1,000 or greater, and the date, location, details and costs of these events. |
| ATI 126 | Request for information relating to DNA probes. |
| ATI 125 | Request for information relating to Nobilis SG9R. |
| ATI 124 | Request for information relating to the VMD’s organisational structure. |
| ATI 123 | Request for information relating to the VMD's use of translation services. |
| ATI 122 | Information relating to key personnel within the VMD. |
| ATI 121 | Information relating to corporate issues within the VMD. |
| ATI 120 | Information relating to corporate issues within the VMD. |
| ATI 119 | Request for veterinary lincomycin usage statistics, going back at least as far as 1998 (or earlier if these are available). |
| ATI 118 | Request for information on the incidence of Suspected Adverse Events (SARs) involving Rimadyl. |
| ATI 117 | Request for information relating to the ecotoxicological data submitted by Merial when Clorsulon was approved for use and the ecotoxicological data for Oxfendazole when given in bolus form, for example as Autoworm First Grazer and Autoworm Finisher. |
| ATI 116 | Request for all correspondence between the Veterinary Residues Committee and food production companies related to testing plans for imported animals. |
| ATI 115 | Request for information in relation to the product: Orbeseal Dry Cow Intramammary Suspension. |
| ATI 114 | Request for information in the Environmental Risk Assessments for the products Fenflor and Shotaflor. |
| ATI No. | Subject |
|---|---|
| ATI 113 | List of all products and amounts for which the VMD has granted permission to import a product for use under a STC or SIC. |
| ATI 112 | Corporate Documents. |
| ATI 111 | Information relating to key personnel. |
| ATI 110 | Hampton Consultation. |
| ATI 109 | Information relating to VMD's contracts for multi function devices, photocopiers and printers. |
| ATI 108 | Information relating to key personnel. |
| ATI 107 | Information relating to Information Communication Technology. |
| ATI 106 | Information in regards to key personnel within our organisation. |
| ATI 105 | Information relating to leases (excluding property). |
| ATI 104 | GMP status and products for the company Diamond Laboratories, also known as Diamond Animal Health, also known as Heska Corporation. |
| ATI 103 | Narrowed down request for information relating to the marketing authorisation for Nobilis SG9R (see ATI0097). |
| ATI 102 | Request to supply the total UK usage of Permethrin and Cypermethrin for 2006. |
| ATI 101 | Request for information on Estates and Facilties Management SLAs. |
| ATI 100 | Request for information on the VMD's Corporate Business. |
| ATI No. | Subject |
|---|---|
| ATI 099 | Information on the VMD's ICT systems. |
| ATI 098 | Information about the reference product upon which the copy cat license for Kloxerate Plus DC is based. |
| ATI 097 | Information relating to the marketing authorisation for Nobilis SG9R. |
| ATI 096 | Request for information regarding results of clinical trials performed by Pfizer, which demonstrate the safety and efficacy of Rimadyl. |
| ATI 095 | Information about dealings between the VPC and public affairs firms in the last five years. |
| ATI 094 | Disposal of antibiotic data. |
| ATI 093 | Request relating to VMD's use of video conferencing. |
| ATI 092 | Information about Information Communication Technology strategy and costs for the VMD. |
| ATI 091 | Number of samples tested for Malachite Green Leucomalachite Green in farmed salmon since 2001, including names of companies. |
| ATI 090 | Information relating to the Norbrook v MAFF Judicial Review. |
| ATI 089 | A copy of the VMD's IT Strategy and IT staff hierarchy. |
| ATI 088 | Information relating to aquatic environmental incidents reported in MAVIS 62. |
| ATI 087 | Information relating to horses being given virginiamycin through the STA system. |
| ATI 086 | Further information to requests dated 20&21/2 - information as per ATI0081 but up to date. |
| ATI 085 | Information related to letter dated 16/1/07 with a copy of any subsequent communications between the VMD and the ACA in relation to Synthetic Pyrethroid (SP) sheep dips. |
| ATI 084 | All documentation and information pertaining to Crystal Violet contamination of Chilean farmed salmon. |
| ATI 083 | Specific details of contact with the Chilean government and farming industry or any other companies including Findus in relation to positive Crystal Violet sample. |
| ATI 082 | Cancelled - incorrectly logged as new ATI but was a request for an internal review of ATI0078 |
| ATI 081 | Any new information on Crystal Violet to include any contact with the Chilean government or any companies and other stakeholders. |
| ATI 080 | All correspondence between manufacturers, NOAH or anyone acting for them, since 1/1/05, concerning synthetic pyrethroid sheep dips. |
| ATI 079 | Further information relating to Special Import Certificates |
| ATI 078 | Information on Crystal Violet in farmed salmon. |
| ATI 077 | Data, including unpublished data, relating to the effect of the administration of avoparcin on salmonella load/shedding in cattle, sheep and pigs. |
| ATI 076 | Information relating to Special Import Certificates system. |
| ATI 075 | Safety data concerning veterinary medicines containing tetracycline antibiotics as the active ingredient and feed additives containing avoparcin as active ingredient. |
| ATI No. | Subject |
|---|---|
| ATI 074 | Information held by the VMD on the origin of permethrin in UK fleeces in 2005. |
| ATI 073 | Copies of the draft reports by the CSL into sheep dip run-off studies and the fording of watercourses. |
| ATI 072 | Any letters received since the suspension of MAs from the manufacturers of the SP sheep dips concerned or anyone acting on their behalf (relates to ATI0063). |
| ATI 071 | Request for further information on representations made to the VMD/VPC by third parties e.g. the ACA. |
| ATI 070 | Identities of retailers providing information for the VRC Annual Report. |
| ATI 069 | Information submitted as part of the application for an MA for Vivitonin. |
| ATI 068 | Information on farmed salmon samples tested as positive for Malachite Green. |
| ATI 067 | Detailed information relating to contracts for hardware, software, telephony etc. |
| ATI 066 | Further requests in relation to Lelystad (Dutch) tuberculin. Opened as a new ATI as advised by IMD. |
| ATI 065 | Request for more detailed information on adverse reactions to flea treatments in which Pyrethrins, Pyrethrum Extract and Piperonyl Butoxide are active ingredients. |
| ATI 064 | Information on MA for Cooper Cattle Dip ad Sheep Dip. |
| ATI 063 | Information relating to representations made by lobbying groups with regard to Cypermethrin based sheep dips. |
| ATI 062 | Request for details of adverse reactions to flea treatments in which Pyrethrins, Pyrethrum Extract and Piperonyl Butoxide are active ingredients. |
| ATI 061 | Information relating to VMD properties and leaseholds. |
| ATI 060 | Request for information on the evidence leading to the suspension of the Marketing Authorisation for Ecofleece. |
| ATI 059 | Further requests in relation to Lelystad (Dutch) tuberculin. Opened as a new ATI as advised by IMD. |
| ATI 058 | Information on PSA targets and specific documents relating to IT services. |
| ATI 057 | Information concerning imported Lelystad (Dutch) tuberculin for use in the intradermal skin test for detecting bovine TB in cattle. |
| ATI 056 | Information relating to the East Cheshire Chemical Company. |
| ATI 055 | Correspondence between the VMD and Pfizer relating to the granting of the MAs for Rimadyl Small Animal Injection and Rimadyl Tablets 20, 50 and 1000mg and Financial links between VMD staff and Pfizer or any other pharmaceutical company. |
| ATI 054 | Request for detailed information relating to the Marketing Authorisation for Rimadyl Small Animal Injection VM00057/4193 and contra-indications. Contained a request for an internal review on ATI0053 - see above. |
| ATI 053 | Information relating to the Marketing Authorisation granted for Rimadyl. |
| ATI 052 | Information relating to the approval of applications for Wilko dog flea and tick drops and Canac dog flea drops. |
| ATI 051 | Detailed information relating the applications for Marketing Authorisations for cypermethrin sheep dip products. |
| ATI 050 | All correspondence, both internal and external, relating to the ban on cypermethrin based sheep dips. |
| ATI 049 | Evidence leading to the suspension of the Marketing Authorisation for Ecofleece. |
| ATI 048 | Evidence on which the suspension of the Marketing Authorisation for Robust was based. |
| ATI 047 | Environmental Risk Assessments for cypermethrin based sheep dips. |
| ATI 046 | Information about the manufacturing site addresses for Tylan G20 Premix, Eli Lilly and Company. |
| ATI 045 | Narrowed down request for information on the efficacy of and specific criteria used by the UK to approve Rabies vaccines. |
| ATI 044 | Request for recent correspondence to enable applicant to ascertain the chain of events in the investigation/prosecution of John Burns of Burns Pet Nutrition Ltd. |
| ATI 043 | All correspondence generated as part of ATI0033. |
| ATI 042 | Information on the efficacy of rabies vaccines - expert advice and relevant facts in relation to the efficacy of rabies vaccines and the UK's position on vaccines in relation to quarantine rules. |
| ATI 041 | Cadmium testing in Norwegian salmon. |
| ATI No. | Subject |
|---|---|
| ATI 040 | Formulations containing praziquantel that are authorized in the UK for cat and dog use. |
| ATI 039 | Medicinal claims made by Burns Pet Nutrition Ltd and specific information on the number and nature of complaints made to the VMD about pet food companies making medicinal claims about their pet foods. |
| ATI 038 | All papers relating to the Defra vs Burns Pet Nutrition Ltd court case. |
| ATI 037 | Medicinal claims made by Burns Pet Nutrition and information on complaints made against pet food companies. |
| ATI 036 | Information on Founderguard use released in 2001. |
| ATI 035 | Study endpoints of the studies on physical-chemical properties, environmental fate and behaviour, ecotoxicology, and analytical methods for soil groundwater and surface water, for the active ingredient lincomycin, for all registered products. |
| ATI 034 | Assessment reports prepared by the VMD for all aspects of target animal safety and of preclinical and clinical efficacy, and Expert reports prepared by the company for all aspects of target animal safety and of preclinical and clinical efficacy in respect of Fortekor: VM 12501/4129, Vm 12501/4029 and Vm 12501/4030, held by Novartis Animal Health. |
| ATI 033 | Information on environmental risk assessments Novartis' product Robust & Bimeda's product Ecofleece. |
| ATI 032 | Request for sight of DCA advice on ATI0020. |
| ATI 031 | Request for Staff handbook. |
| ATI 030 | Correspondence between the VMD and Joanna Tuffnell/PRI Group between the 27 August 2004 and 15 July 2005, when Joanna Tuffnell/PRI Group was providing consultancy support for Global Genetics application up until the 12 August, when VMD received notification that the arrangement had ended. |
| ATI 029 | 3rd party complaints about Nestle product. |
| ATI 028 | Non-Stat results of testing 3rd country imports. |
| ATI 027 | Information relating VMD and vehicle insurance. |
| ATI 026 | Results of tests on sheep dip products 1985-2005. |
| ATI 025 | Disclosure of the identity of complainants against Biotal. |
| ATI 024 | Use of cypermethrin as sheep dip in West Wales. |
| ATI 023 | Synthetic pyrethroid sheep dip environmental incidents. |
| ATI 022 | Request for a full list of ingredients for Aquaguard Sea Lice Treatment. |
| ATI 021 | Request from Norbrook Laboratories for correspondence between Dr. Quinn and the VMD. |
| ATI 020 | Use of Founderguard in the UK. |
| ATI 019 | The use of cypermethrin as a sheep dip in West Wales. |
| ATI 018 | Request covering a range of issues relating to ATI 008. |
| ATI 017 | Regarding batches of veterinary immunological products. |
| ATI 016 | Requesting information on the court proceedings against Burns Pet Nutrition Ltd. |
| ATI 015 | The veterinary poultry salmonella vaccines used in the UK. |
| ATI 014 | Relating to pimobendan. |
| ATI 013 | Correspondence we hold between Hills Pet Nutrition Ltd and the VMD concerning Hills' Prescription Diet i/d and what changes were requested and made to Hills' promotional literature. |
| ATI 012 | Correspondence between VMD and named companies on unauthorised medicinal claims. |
| ATI 011 | Presence of streptomycin in tropical honeys, with the purpose of proving that this antibiotic can be naturally occurring in honey. |
| ATI 010 | Details of prosecutions taken by the Veterinary Medicines Directorate and / or Defra / MAFF where a product which is deemed to be medicinal has been presented for sale without a marketing Authorisation. |
| ATI 009 | Use of cypermethrin as sheep dip in West Wales. |
| ATI 008 | Request covering a range of issues. |
| ATI 007 | Relating residue surveillance import data. |
| ATI 006 | Relating to the unlicensed medicinal claims and marketing of pet foods carried out by Burns Pet Nutrition Ltd. |
| ATI 005 | Cost of the Independent Review of Dispensing and the competition commission investigation. |
| ATI 004 | The autopsy papers which were obtained from cattle on which organophosphates were tested in the effort to remove the threat of warble fly infestation. |
| ATI 003 | Information in relation to the Judicial Review Maff v Norbrook Laboratories Ltd. |
| ATI 002 | Review and evaluation of diazinon conducted in the late 90's / early 2000's for re-registration as an ectoparasite control agent (sheep dip). |
| ATI 001 | Information about Rimadyl and on the VMD's traffic light document on the release of human and veterinary medicines regulatory information. |
Last Updated: 21 January 2011
